Search results
Results from the WOW.Com Content Network
"I Miss You" is a hit single recorded by American R&B and pop band Klymaxx for their fourth album, Meeting in the Ladies Room (1984). Written and co-produced by Klymaxx keyboardist Lynn Malsby, the song was released as the album's third single.
The title track reached No. 59 on the Hot 100 and No. 4 on the R&B chart. The third single, "I Miss You", reached No. 5 on the Hot 100, No. 11 on the R&B chart and No. 1 on the adult contemporary chart and was certified gold. The fourth, and final, single, "Lock and Key", reached No. 47 on the R&B chart.
Klymaxx was created and formed in 1979 by Bernadette Cooper (producer/drummer/vocals); she also created the name klymaxx. The other original members included Lorena "Lungs" Porter Shelby (lead vocals), Cheryl Cooley (guitar), Robbin Grider (keyboards/guitar), and Lynn Malsby (keyboards).
You might experience a solo ruined orgasm if you stop or ease up on genital stimulation just before you reach your climax. If your partner is the one getting you off, they can ruin your orgasm by ...
Climax descended from the 1960s hit band The Outsiders. [3] Former Outsiders members Geraci, Nims, and D'Amico, along with new member Guttman recorded and released one single under the Outsiders name ("Changes"/"Lost in My World") and another issued as a solo single by Geraci ("Lovin' You"/"Think I'm Fallin'"), but when Tom King of the original band threatened legal action, the name of the ...
"Precious and Few" is a song recorded by American group Climax which became a major North American hit in early 1972. The song was written by the band's guitarist, Walter D. Nims. [ 3 ] Background
"I Love You" was also covered by the band the H Factor, and was released as a single, from their 1989 sole eponymous album. Two members of the H Factor, Pete Haycock and Derek Holt, were members of the Climax Blues Band before forming the H Factor with Steve Hunter.
Anorgasmia (difficulty experiencing climax) is a noted side effect of Lexapro. In women, clinical trials of escitalopram for depression found that roughly two to six percent of users reported ...